The QBE result was quite a miss, relative to consensus estimates (underlying NPAT $805m, vs consensus at $850m).

The forward guidance on dividends was also lower than the market anticipated, and both of these issues overshadowed what we thought was nonetheless a good result.

Firstly, the key metrics.

Claims ratios continue to trend favourably, with the attritional claims ratio seeing sequential improvement.

Expense ratios continued to be well managed.

The net impact is that the all important combined operating ratio is comfortably under 100, and thus QBE’s result was amongst the best it’s had in years.

The years of poor returns (lower investment income, higher claims ratios, industry competition) eventually paved the way for a stronger pricing cycle, to improve overall industry profitability.

That pricing cycle (referred to as an insurance “hardening” cycle) is evident in the segmental revenues shown below.

But perhaps even more so when viewed via growth rates.

And the aforementioned ratio improvement equated to a strong underwriting profit, again, the best in years.

Investment income is usually added to the underwriting profits, to give a sense of the overall insurance margin. And investment income has been virtually non-existent, given the pandemic impact on yields.

That’s why QBE has some of the best leverage to rising rates in the market.

However, there is a caveat, in that if inflation, specifically resulting in claims inflation, rises, but bond yields don’t rise by as much, QBE can face a squeeze, that requires an even firmer pricing response (which then takes longer to recoup margins).

This is what appears to be playing out at present (we can all see US inflation at 7.5%, versus 10 year bond yields at 2%). Now it is extremely unlikely that inflation stays at 7.5%, with yields staying so low, over the longer run.

Either yields go up, or inflation goes down, or some combination thereof. So we don’t see this as an especially negative risk to QBE.

Hence, we prefer to focus on the good operational outcomes, the improved underwriting profits, and the prospect of higher investment income down the track.

QBE continues to provide us with good US dollar exposure (hedge against a falling AUD), and likewise the positive beta to higher rates.

The higher claims inflation, and the higher industry uncertainty associated with COVID have caused QBE to be more cautious on the dividend. Whilst this is disappointing from a yield perspective, we are not really in QBE for the current yield.

Overall, we remain (fairly) happy holders.

Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.

This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.

Please note that past performance is not a reliable indicator of future performance.

General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.

Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.

Receive our investment insights

Something went wrong. Please check your entries and try again.